Skip to main content
SupplementScience

Benefits of Phenylpiracetam

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Cognitive enhancement — phenylpiracetam enhances memory, attention, and problem-solving through modulation of NMDA and AMPA glutamate receptors, with added dopaminergic stimulation for motivation
  • Psychostimulant properties — the phenyl group adds stimulant-like effects on dopamine and norepinephrine systems, providing clean energy and motivation without the jitteriness of traditional stimulants
  • Physical performance — phenylpiracetam increases physical endurance and cold tolerance, which is why it was developed for Soviet/Russian cosmonauts and is banned by WADA in athletic competition
  • Cognitive recovery — Russian clinical trials showed phenylpiracetam improved cognitive function in stroke patients and individuals with chronic cerebrovascular insufficiency (Savchenko et al., 2005)
  • Anti-amnesic effects — animal studies demonstrate phenylpiracetam reverses experimentally induced amnesia more potently than piracetam across multiple models

What the Research Says

Phenylpiracetam was developed at the Russian Academy of Sciences in the 1980s and has been studied primarily in Russian clinical literature. Savchenko et al. (2005) demonstrated cognitive improvements in stroke patients. Malykh and Sadaie (2010) reviewed the racetam family and noted phenylpiracetam's superior potency and additional psychostimulant properties. Its WADA ban validates its performance-enhancing effects. Western clinical trial data is limited, and most evidence comes from Russian research and widespread anecdotal use in the nootropics community.

Related Conditions

FocusBrain FogEnergy
Full Phenylpiracetam Guide

References

  1. (). The phenotropil treatment of the consequences of brain organic lesions. Zhurnal Nevrologii i Psikhiatrii imeni SS Korsakova.
  2. (). Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs. DOI
  3. (). The effects of scopolamine and the nootropic drug phenotropil on rat brain neurotransmitter receptors during testing of the conditioned passive avoidance task. Neurochemical Journal. DOI